17 Einträge gefunden

1. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.

   1. Nazareno, Suardi
   2. Porter, Christopher R
   3. Reuther, Alwyn M
   4. Walz, Jochen
   5. Kodama, Koichi
   6. Gibbons, Robert P
   7. Correa, Roy

   2008 - Forschungsinformationssystem des UKE
2. Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.

   1. Shariat, Shahrokh F
   2. Walz, Jochen
   3. Roehrborn, Claus G
   4. Montorsi, Francesco
   5. Jeldres, Claudio
   6. Saad, Fred
   7. Karakiewicz, Pierre I

   2008 - Forschungsinformationssystem des UKE
3. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.

   1. Jeldres, Claudio
   2. Suardi, Nazareno
   3. Saad, Fred
   4. Montorsi, Francesco
   5. Shariat, Shahrokh F
   6. Perrotte, Paul
   7. Bhojani, Naeem

   2008 - Forschungsinformationssystem des UKE
4. Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.

   1. Nazareno, Suardi
   2. Capitanio, Umberto
   3. Chun, Felix
   4. Graefen, Markus
   5. Perrotte, Paul
   6. Schlomm, Thorsten
   7. Haese, Alexander

   2008 - Forschungsinformationssystem des UKE
5. Effect of nightly versus on-demand vardenafil on recovery of erectile function in men following bilateral nerve-sparing radical prostatectomy.

   1. Montorsi, Francesco
   2. Brock, Gerald
   3. Lee, Jay
   4. Shapiro, JoAnn
   5. Hendrik, Van Poppel
   6. Graefen, Markus
   7. Stief, Christian

   2008 - Forschungsinformationssystem des UKE
6. High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer.

   1. Jeldres, Claudio
   2. Nazareno, Suardi
   3. Capitanio, Umberto
   4. Montorsi, Francesco
   5. Shariat, Shahrokh F
   6. Perrotte, Paul
   7. Peloquin, Francois

   2008 - Forschungsinformationssystem des UKE
7. Baseline prevalence of erectile dysfunction in a prostate cancer screening population.

   1. Walz, Jochen
   2. Perrotte, Paul
   3. Suardi, Nazareno
   4. Hutterer, Georg
   5. Jeldres, Claudio
   6. Bénard, Francois
   7. Valiquette, Luc

   2008 - Forschungsinformationssystem des UKE
8. Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.

   1. Gallina, Andrea
   2. Nazareno, Suardi
   3. Montorsi, Francesco
   4. Capitanio, Umberto
   5. Jeldres, Claudio
   6. Saad, Fred
   7. Graefen, Markus

   2008 - Forschungsinformationssystem des UKE
9. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

   1. Walz, Jochen
   2. Nazareno, Suardi
   3. Hutterer, Georg C
   4. Perrotte, Paul
   5. Gallina, Andrea
   6. Bénard, Francois
   7. Valiquette, Luc

   2008 - Forschungsinformationssystem des UKE
10. Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks.

    1. Isbarn, Hendrik
    2. Boccon-Gibod, Laurent
    3. Carroll, Peter R
    4. Montorsi, Francesco
    5. Schulman, Claude
    6. Smith, Matthew R
    7. Sternberg, Cora N

    2008 - Forschungsinformationssystem des UKE
11. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

    1. Jeldres, Claudio
    2. Suardi, Nazareno
    3. Walz, Jochen
    4. Saad, Fred
    5. Hutterer, Georg C
    6. Bhojani, Naeem
    7. Shariat, Shahrokh F

    2008 - Forschungsinformationssystem des UKE
12. Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

    1. Chun, Felix
    2. Suardi, Nazareno
    3. Capitanio, Umberto
    4. Jeldres, Claudio
    5. Ahyai, Sascha
    6. Graefen, Markus
    7. Haese, Alexander

    2008 - Forschungsinformationssystem des UKE
13. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

    1. Walz, Jochen
    2. Haese, Alexander
    3. Scattoni, Vincenzo
    4. Steuber, Thomas
    5. Chun, Felix
    6. Briganti, Alberto
    7. Montorsi, Francesco

    2008 - Forschungsinformationssystem des UKE
14. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.

    1. Walz, Jochen
    2. Montorsi, Francesco
    3. Jeldres, Claudio
    4. Nazareno, Suardi
    5. Shariat, Shahrokh F
    6. Perrotte, Paul
    7. Arjane, Philippe

    2008 - Forschungsinformationssystem des UKE
15. Is node-positive prostate cancer always a systemic disease?

    1. Briganti, Alberto
    2. Chun, Felix
    3. Karakiewicz, Pierre I
    4. Rigatti, Patrizio
    5. Montorsi, Francesco

    2008 - Forschungsinformationssystem des UKE
16. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.

    1. Shariat, Shahrokh F
    2. Karam, Jose A
    3. Walz, Jochen
    4. Roehrborn, Claus G
    5. Montorsi, Francesco
    6. Margulis, Vitaly
    7. Saad, Fred

    2008 - Forschungsinformationssystem des UKE
17. Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.

    1. Gallina, Andrea
    2. Chun, Felix
    3. Nazareno, Suardi
    4. Eastham, James A
    5. Perrotte, Paul
    6. Graefen, Markus
    7. Hutterer, Georg

    2008 - Forschungsinformationssystem des UKE